Robles-Plaza M, Gómez-Peralta F, Bellido V, Ampudia-Blasco FJ, Carretero-Gómez J, Cebrián-Cuenca AM, de la Cuadra-Grande A, Mezquita-Raya P
Cost-Utility Analysis of FreeStyle Libre Systems in People with Type 2 Diabetes Mellitus on Treatment with Basal Insulin and Poor Glycemic Control in Spain
Diabetes Ther. 2025. doi: 10.1007/s13300-025-01816-6
Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E
Cost-Effectiveness Analysis of Etrasimod compared with Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain
Pharmacoecon Open. 2025. doi: 10.1007/s41669-025-00619-6
Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J
Cost-effectiveness of community interventions to promote awareness, testing and treatment of of hepatitis B and C in the migrant population in Catalonia
Jornada Científica CIBERESP. Zaragoza. 28-29 oct 2025
Olveira A, Domínguez-Hernández R, Cano S, Andaluz I, Castillo P, Romero M, García-Samaniego J, García A, Abadía M
Reconnecting Hepatitis C Patients Lost to Follow-Up: A targeted Strategy
Rev Esp Enferm Dig. 2025. doi: 10.17235/reed.2025.11527/2025
Rodríguez-Lago I, Muñoz Núñez F, Lucendo AJ, De Lossada Juste A, Cabez A, de la Cuadra-Grande A, Oyagüez I, Monte-Boquet E
Cost-effectiveness analysis of etrasimod compared with biologic therapies for patients with moderate-to-severe active ulcerative colitis experienced to previous advanced therapies in Spain
United European Gastroenterology (UEG) Week. Berlin. 4-7 oct 2025
Martró E, Domínguez-Hernández R, Forero V, Gómez J, Not A, Manzanares-Laya S, Montoro M, Gómez-Barrera M, Buti M, Casabona J, Majó X, Colom J